Reference health
Nanoformulated Codelivery of Quercetin and Alantolactone Promotes an Antitumor Response through Synergistic Immunogenic Cell Death for Microsatellite-Stable Colorectal Cancer
70/70 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 70 checked references that resolve
resolves10.7150/jca.7987
Current Approaches and Challenges for Monitoring Treatment Response in Colon and Rectal Cancer
resolves10.1016/j.vaccine.2017.03.067
Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis
resolves10.1016/j.jconrel.2018.07.007
Targeting of drug-loaded nanoparticles to tumor sites increases cell death and release of danger signals
resolves10.1016/j.immuni.2018.03.004
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
resolves10.1159/000489979
Novel Therapeutic Strategies for Solid Tumor Based on Body’s Intrinsic Antitumor Immune System
resolves10.1016/j.cyto.2017.05.024
Cytokines in immunogenic cell death: Applications for cancer immunotherapy
resolves10.1016/j.immuni.2015.11.024
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
resolves10.1038/s41467-018-04605-x
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
resolves10.3390/ijms19102922
Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
resolves10.1002/ijc.28070
Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
resolves10.1158/1078-0432.CCR-16-1666
Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell Activity
resolves10.1038/cddis.2013.207
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
resolves10.3390/molecules23112906
Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
resolves10.1038/s41467-017-01651-9
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
resolves10.1021/acsnano.8b01890
Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma
resolves10.3109/01480545.2010.494664
Toxic effects of celastrol on embryonic development of zebrafish (<i>Danio rerio</i>)
resolves10.1186/s12957-018-1400-z
Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways
resolves10.1016/j.bbrc.2018.02.044
Quercetin restrains TGF-β1-induced epithelial–mesenchymal transition by inhibiting Twist1 and regulating E-cadherin expression
resolves10.1016/j.urolonc.2011.10.009
Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells
resolves10.1093/jn/138.9.1615
Daily Quercetin Supplementation Dose-Dependently Increases Plasma Quercetin Concentrations in Healthy Humans
resolves10.1016/j.intimp.2012.08.011
Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells
resolves10.1155/2013/248532
Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
resolves10.1016/j.canlet.2014.11.049
Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
resolves10.1002/iub.1068
Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction
resolves10.3892/ol.2016.4175
Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma
resolves10.1007/s10495-016-1334-2
Quercetin induces protective autophagy and apoptosis through ER stress via the p-STAT3/Bcl-2 axis in ovarian cancer
resolves10.1002/adfm.201401076
Nanoparticles with Precise Ratiometric Co‐Loading and Co‐Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer
resolves10.1007/s11095-017-2340-y
Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration
resolves10.1016/j.ejpb.2006.06.003
Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs
resolves10.1016/j.biomaterials.2011.02.022
Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy
resolves10.1016/j.ejphar.2011.09.023
Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery
resolves10.1038/mt.2013.120
Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC
resolves10.1016/j.canlet.2005.09.013
Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells
resolves10.1002/jbt.21685
Alantolactone Induces Apoptosis and Cell Cycle Arrest on Lung Squamous Cancer SK‐MES‐1 Cells
resolves10.1080/2162402X.2018.1477459
Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment
resolves10.1158/0008-5472.CAN-12-3981
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
resolves10.3748/wjg.v20.i47.17699
Toll-like receptor signaling in colorectal cancer: Carcinogenesis to cancer therapy
resolves10.1186/s13046-017-0563-8
Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades
resolves10.4049/jimmunol.1701231
Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function
resolves10.1038/srep46652
Elevated circulating levels of the interferon-γ–induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still’s disease
resolves10.1002/jcp.26118
β‐asarone inhibited cell growth and promoted autophagy via P53/Bcl‐2/Bclin‐1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells
resolves10.1371/journal.pone.0157251
Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade
resolves10.1016/j.bbrc.2008.06.077
The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways
resolves10.1038/sj.bjp.0703397
Inhibition of mitochondrial proton F0F1‐ATPase/ATP synthase by polyphenolic phytochemicals
resolves10.1016/j.jconrel.2014.03.016
Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model
resolves10.1016/0065-2571(84)90007-4
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
resolves10.1016/j.carbpol.2011.06.008
Low molecular weight heparin-all-trans-retinoid acid conjugate as a drug carrier for combination cancer chemotherapy of paclitaxel and all-trans-retinoid acid
resolves10.1016/j.ijpharm.2018.09.053
Soluplus micelles for acyclovir ocular delivery: Formulation and cornea and sclera permeability
resolves10.1080/03639045.2017.1349784
Polysialic acid and pluronic F127 mixed polymeric micelles of docetaxel as new approach for enhanced antitumor efficacy
resolves10.1021/acsami.7b18699
Multifunctional Glycoconjugate Assisted Nanocrystalline Drug Delivery for Tumor Targeting and Permeabilization of Lysosomal-Mitochondrial Membrane
resolves10.2147/IJN.S193783
<p>One-step mechanochemical preparation and prominent antitumor activity of SN-38 self-micelle solid dispersion</p>
resolves10.1039/C9RA01381D
Construction of novel multifunctional luminescent nanoparticles based on DNA bridging and their inhibitory effect on tumor growth
The 3 references without a DOI — listed, not checked
no DOI — not checkedAmerican Cancer Society. Cancer Facts & Figures 2019; American Cancer Society: Atlanta, 2019; pp 9–15.
no DOI — not checkedref4/cit4
no DOI — not checkedref60/cit60
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1021/acsnano.9b02875"><img src="https://citestamp.com/citestamped/10.1021/acsnano.9b02875/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1021/acsnano.9b02875)